Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis : systematic review and meta-analysis
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4498638
Author(s) Santos, V. S.; Goletti, D.; Kontogianni, K.; Adams, E. R.; Molina-Moya, B.; Dominguez, J.; Crudu, V.; Martins-Filho, P. R. S.; Ruhwald, M.; Lawson, L.; Bimba, J. S.; Garcia-Basteiro, A. L.; Petrone, L.; Kabeer, B. S.; Reither, K.; Cuevas, L. E.
Author(s) at UniBasel Reither, Klaus
Year 2019
Title Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis : systematic review and meta-analysis
Journal Clinical Microbiology and Infection
Volume 25
Number 2
Pages / Article-Number 169-177
Abstract We examined the data reported in studies for diagnostic purposes and to discuss whether their intended use could be extended to triage, as rule-in or rule-out tests to select individuals who should undergo further confirmatory tests.; We searched Scopus, PubMed and Web of Science with the terms 'acute phase proteins,' 'IP-10,' 'tuberculosis,' 'screening' and 'diagnosis,' extracted the sensitivity and specificity of the biomarkers and explored methodologic differences to explain performance variations. Summary estimates were calculated using random-effects models for overall pooled accuracy. The hierarchical summary receiver operating characteristic model was used for meta-analysis.; We identified 14, four and one studies for C-reactive protein (CRP), interferon γ-induced protein 10 (IP-10) and alpha-1-acid glycoprotein (AGP). The pooled CRP sensitivity/specificity (95% confidence interval) was 89% (80-96) and 57% (36-65). Sensitivity/specificity were higher in high-tuberculosis-burden countries (90%/64%), HIV-infected individuals (91%/61%) and community-based studies (90%/62%). IP-10 sensitivity/specificity in TB vs. non-TB studies was 85%/63% and in TB and HIV coinfected vs. other lung conditions 94%/21%. However, IP-10 studies included diverse populations and a high risk of bias, resulting in very low-quality evidence. AGP had 86%/93% sensitivity/specificity.; Few studies have evaluated CRP, IP-10 and AGP for the triage of symptomatic patients. Their high sensitivity and moderate specificity warrant further prospective studies exploring whether their combined use could optimize performance.
Publisher Elsevier
ISSN/ISBN 1469-0691
edoc-URL https://edoc.unibas.ch/69183/
Full Text on edoc Available
Digital Object Identifier DOI 10.1016/j.cmi.2018.07.017
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/30076971
ISI-Number WOS:000456747400010
Document type (ISI) Journal Article, Review
 
   

MCSS v5.8 PRO. 0.345 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
25/04/2024